Immunocore Holdings - ADR

$36.38 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About Immunocore Holdings - ADR

Immunocore Holdings Limited operates as a holding company. The Company, through its subsidiaries, develops and commercializes a new generation of transformative medicines to address unmet needs in cancer, infection, and autoimmune diseases. Immunocore Holdings serves customers in the United Kingdom and the United States.

Stock Analysis

last close $36.38
1-mo return -4.3%
3-mo return 22%
avg daily vol. 50.66T
52-week high 61.99
52-week low 27.77
market cap. $1.7B
forward pe -
annual div. -
roe -134.2%
ltg forecast -
dividend yield -
annual rev. $27M
inst own. 38.1%

Subscribe now for daily local and international financial news